Response to "Is the outcome of SARS-CoV-2 infection in solid organ transplant recipients really similar to that of the general population?"
George J AlangadenRamesh S MayurPublished in: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (2021)
We thank the authors Maria Mendoza et al. (1) for their comments related to our publication on the clinical characteristics and outcomes of COVID-19 in solid organ transplant (SOT) recipients (2). Our study included a cohort of 47 consecutive SOT recipients with COVID-19. As noted in our study the 12 patients with mild to moderate COVID-19 that were treated as outpatients were excluded from the analysis to avoid potential selection bias. The study therefore compares 35 hospitalized SOT and 100 hospitalized non-transplant patients with COVID-19.